Identity
- Trade Name
- Reticcount FDA UDI
- Generic Name
- Reticulocyte count IVD, reagent FDA UDI
- Device Name
- Retic-Count Reticulocyte Rgnt System IVD FDA UDI
- Model / Reference
- 349204 FDA UDI
- Description
- Retic-Count Reticulocyte Rgnt System IVD FDA UDI
Identifiers
- Catalog Number
- 349204 FDA UDI
- Primary DI / UDI-DI
- 00382903492046 FDA UDI
- FDA Product Code
- GKL FDA UDI
- GMDN Term
- Reticulocyte count IVD, reagent FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 864.5200 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Reticulocyte count IVD, reagent
Reticcount by Becton Dickinson And Company — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Reticulocyte count IVD, reagent.
- COULTER LH Series Retic Pak Reagent Kit — Beckman Coulter, Inc. · Class I
- Reti-TIC — BIOANALYTIC GmbH, biomed. Analysentechnik · Class I
- Reti-TIC — BIOANALYTIC GmbH, biomed. Analysentechnik · Class I
- Brillant Cresyl Blue Solution Isotonic — BIOANALYTIC GmbH, biomed. Analysentechnik · Class I
- COULTER ReticPrep — Beckman Coulter, Inc. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Becton Dickinson And Company
Sources (1)
- FDA UDI cd3c1d4a-a984-4bd7-b444-438f4e1e72c0 36 fields · synced Jun 8, 2026